The Latest
-
J&J plans to spin out orthopedics business
CEO Joaquin Duato said the spinout will help the healthcare giant focus on medtech areas with higher growth and margins, such as cardiovascular and robotics.
-
Abbott CEO: ‘We’re right on time’ to the PFA party
As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors that the company is not just playing defense.
-
To move or not to move? Manufacturers hesitant to nearshore before USMCA review
While some companies are using regional supply chains or leaning on tariff exemptions by maximizing compliance, others are frozen in place.
-
Stereotaxis teams with CardioFocus to develop robotic PFA system
Stereotaxis CEO David Fischel said the precision, stability and safety profile of robotics are a good fit for pulsed field ablation.
-
Cybersecurity triggers another recall of J&J’s Impella heart pump controller
While no patients have been harmed, the FDA categorized the action as a Class I recall because of the potential for serious injury or death.
-
Trump administration moves to fire HHS employees amid shutdown
Upwards of 1,000 HHS employees were affected. However, the department has rolled back some of the layoffs at the CDC, where the brunt of the terminations were concentrated.
Updated Oct. 14, 2025 -
Intuitive expands AI in Ion; Horizon performs first robotic cataract surgery
The FDA cleared AI and imaging updates for Intuitive’s lung biopsy robot. Elsewhere, Horizon completed the first cataract surgery with its robotic system, and MMI began a neurosurgical study.
-
Zimmer launches 2 devices from $1.1B orthopedic takeover
After acquiring Paragon 28 earlier this year, Zimmer intends to maintain the foot and ankle specialist’s double-digit growth.
-
Intuitive’s challengers continue to advance
Companies creating new robotic platforms marked additional milestones heading into the fourth quarter. Catch up with their progress in this roundup of the latest developments in surgical robotics.
-
FDA’s presence at AdvaMed conference shrinks amid shutdown
Michelle Tarver, director of the Center for Devices and Radiological Health, and other center officials attended virtually as a government shutdown continues.
-
Medtronic begins study of Hugo robot in gynecology
With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on Intuitive Surgical in the U.S. robotic surgery market.
-
AdvaMed CEO: ‘Just give us some certainty’
At AdvaMed’s annual conference, CEO Scott Whitaker addressed policy issues around tariffs, FDA staff cuts and the ongoing government shutdown.
-
Medtech M&A has remained slow this year. But 2 execs are ready to make a deal
Executives from Stryker and Johnson & Johnson are on the hunt for deals, despite a turbulent environment, they said at AdvaMed’s The MedTech Conference.
-
Digital health funding outpacing last year as huge rounds increase: report
Investment in 2025 has reached $9.9 billion, exceeding the $8.4 billion that was raised through the third quarter last year, according to Rock Health.
-
Owens & Minor inks $375M deal to sell unit to investment firm
The sale will leave Owens & Minor focused on a smaller but potentially faster-growing and higher-margin business that provides products directly to patients.
-
Oz speaks out about shutdown, Medicaid cuts, Medicare Advantage audits and more
Six takeaways from the CMS administrator’s appearance at a D.C. think tank Monday — including who’s set to be the next Medicaid director.
-
How 4 medtech CEOs are using AI
At AdvaMed’s The MedTech Conference, executives said they’re incorporating AI in more devices, but figuring out how to use the technology internally is challenging.
-
Q&A
How the FDA’s crackdown on cybersecurity affects medtech firms
MedSec CEO Michelle Jump spoke with MedTech Dive at AdvaMed’s annual meeting about the FDA’s shift from a “carrot” to a “stick” approach in cybersecurity regulation.
-
Top medtech conferences in 2026
The medical device industry has a jam-packed year of events for professionals to attend, including the J.P. Morgan Healthcare Conference, DeviceTalks Boston and AdvaMed’s annual medtech meeting.
-
Convatec plans $1B investment in R&D in the US and UK
Capacity at the company's Boston site will increase by 50% as part of a $600 million, 10-year commitment to the U.S.